Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
AOD 9604 does not interfere with female hormones or menstrual cycles
It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration
The combination creates a context where AOD 9604s lipolytic effect is occurring simultaneously with GH-stimulated protein synthesis and recovery, theoretically allowing fat loss and lean mass preservation to happen in parallel
Inconsistent timing undermines protocol effectiveness
Comparison table: fat loss peptide combinations Cost considerations and practical budgeting Running this combination involves ongoing costs that researchers should budget for before committing to a multi-month protocol
You waste the peptide
